Patents by Inventor Perry Calias

Perry Calias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ocular iontophoretic delivery of dexamethasone and formulations thereof
    Patent number: 10376463
    Abstract: Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: August 13, 2019
    Assignee: Eyegate Pharmaceuticals, Inc.
    Inventors: Mike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
  • Delivery of corticosteroids through iontophoresis
    Patent number: 9820935
    Abstract: Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: November 21, 2017
    Assignee: EyeGate Pharmaceuticals, Inc.
    Inventors: Mike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
  • DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS
    Publication number: 20160263024
    Abstract: Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
    Type: Application
    Filed: March 10, 2016
    Publication date: September 15, 2016
    Inventors: Mike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
  • Delivery of corticosteroids through iontophoresis
    Patent number: 9149525
    Abstract: Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
    Type: Grant
    Filed: October 22, 2013
    Date of Patent: October 6, 2015
    Assignee: EyeGate Pharmaceuticals, Inc.
    Inventors: Mike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20150202289
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: January 30, 2015
    Publication date: July 23, 2015
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • Combination Therapy for the Treatment of Ocular Neovascular Disorders
    Publication number: 20150202288
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: January 16, 2015
    Publication date: July 23, 2015
    Inventors: DAVID SHIMA, PERRY CALIAS, ANTHONY P. ADAMIS
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20140294816
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: June 13, 2014
    Publication date: October 2, 2014
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20140242082
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: February 21, 2014
    Publication date: August 28, 2014
    Applicant: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • Combination therapy for the treatment of ocular neovascular disorders
    Patent number: 8685397
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: April 1, 2014
    Assignee: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS
    Publication number: 20140046242
    Abstract: Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
    Type: Application
    Filed: October 22, 2013
    Publication date: February 13, 2014
    Inventors: Mike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
  • Delivery Of Corticosteroids Through Iontophoresis
    Publication number: 20120283231
    Abstract: Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
    Type: Application
    Filed: May 11, 2012
    Publication date: November 8, 2012
    Applicant: EYEGATE PHARMACEUTICALS, INC.
    Inventors: Mike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
  • Combination therapy for the treatment of ocular neovascular disorders
    Patent number: 8206707
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Grant
    Filed: May 13, 2009
    Date of Patent: June 26, 2012
    Assignee: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • Combination therapy for the treatment of ocular neovascular disorders
    Patent number: 8187597
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: May 29, 2012
    Assignee: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • Combination Therapy for the Treatment of Ocular Neovascular Disorders
    Publication number: 20110200593
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: January 10, 2011
    Publication date: August 18, 2011
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • Combination therapy for the treatment of ocular neovascular disorders
    Patent number: 7759472
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Grant
    Filed: August 26, 2004
    Date of Patent: July 20, 2010
    Assignee: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20100129364
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: December 17, 2009
    Publication date: May 27, 2010
    Applicant: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20100119522
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: September 22, 2009
    Publication date: May 13, 2010
    Applicant: Ophthotech Corporation
    Inventors: David Shima, Perry Calias, Anthony P. Adamis
  • COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
    Publication number: 20100111942
    Abstract: The invention features methods for treating a patient diagnosed with, or at risk of developing, a neovascular disorder by administering a PDGF antagonist and a VEGF antagonist to the patient. The invention also features a pharmaceutical composition containing a PDGF antagonist and a VEGF antagonist for the treatment or prevention of a neovascular disorder.
    Type: Application
    Filed: May 13, 2009
    Publication date: May 6, 2010
    Applicant: OPHTHOTECH CORPORATION
    Inventors: DAVID SHIMA, PERRY CALIAS, ANTHONY P. ADAMIS
  • DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS
    Publication number: 20090306579
    Abstract: Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
    Type: Application
    Filed: February 24, 2009
    Publication date: December 10, 2009
    Inventors: Mike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
  • 5'-and 3'-capped aptamers and uses therefor
    Publication number: 20050096290
    Abstract: The invention provides compositions and methods for the treating disease using aptamers having 5?-5? and 3?-3? inverted nucleotide capped ends. In particular, the invention provides 5?-5? and 3?-3? capped anti-VEGF aptamers for the treatment of neovascularization-related diseases and disorders including age-related macular degeneration.
    Type: Application
    Filed: August 6, 2004
    Publication date: May 5, 2005
    Inventors: Anthony Adamis, David Shima, Francine Wincott, Perry Calias